Diagnosing Insulinoma
The diagnosis of insulinoma requires a supervised 48-72 hour fast demonstrating Whipple's triad with inappropriately elevated insulin, C-peptide, and proinsulin levels when blood glucose falls below 55 mg/dL. 1
Clinical Presentation and Initial Evaluation
- Look for symptoms of hypoglycemia:
- Neuroglycopenic symptoms: confusion, lethargy, periodic numbness
- Adrenergic symptoms: sweating, palpitations, anxiety
- Symptoms typically occur during fasting or exercise
Diagnostic Algorithm
Step 1: Laboratory Testing
- Measure serum insulin, proinsulin, and C-peptide levels 1
- Diagnostic criteria during hypoglycemia (blood glucose <55 mg/dL):
- Insulin level >3 mcIU/mL (usually >6 mcIU/mL)
- C-peptide concentrations ≥0.6 ng/mL
- Proinsulin levels ≥5 pmol/L 1
Step 2: Supervised Fast (Gold Standard)
- Perform a supervised 48-72 hour fast 1
Step 3: Imaging for Localization
- Endoscopic ultrasound (EUS): best initial imaging modality (localizes ~82% of pancreatic NETs) 1
- Multiphasic CT or MRI: should be performed to rule out metastatic disease 1
- Consider selective arterial calcium stimulation test (Imamura-Doppman procedure) only when:
- Other localization tests are equivocal or negative
- For persistent or recurrent insulinoma 1
Important Diagnostic Considerations
Whipple's Triad
Confirm all three elements:
- Symptoms of hypoglycemia
- Low blood glucose (<55 mg/dL) when symptoms occur
- Relief of symptoms after glucose administration
Alternative Testing Methods
- For outpatient settings or when prolonged fast is not feasible:
- 5-hour oral glucose tolerance test (OGTT) with measurement of insulin-to-glucose and C-peptide-to-glucose ratios 3
- Short fasting test (24-hour) initiated overnight at home and continued in outpatient setting 4
- Recent research shows 91.7% of insulinomas can be diagnosed within 24 hours of beginning a fast 4
Pitfalls to Avoid
False negatives: Some insulinomas may present with normoglycemia after prolonged fasting but glucose-stimulated hypoglycemia 5
- Consider OGTT if clinical suspicion is high despite negative fast
Factitious hypoglycemia: Test urinary sulfonylurea to rule out factitious causes 1
Premature termination of fast: Ensure proper monitoring of subtle neuroglycopenic symptoms
Somatostatin analogs: Avoid administering octreotide or lanreotide before diagnosis as they can profoundly worsen hypoglycemia in patients with insulinoma 1
Insulin-to-glucose ratio: An insulin-to-glucose ratio ≥0.3 reflects inappropriate insulin secretion during hypoglycemia 1
By following this diagnostic approach, insulinoma can be accurately diagnosed, allowing for appropriate surgical management which can cure 90% of these tumors that typically follow an indolent course 1.